These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10915920)

  • 1. The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease.
    Brinton RD; Chen S; Montoya M; Hsieh D; Minaya J
    Maturitas; 2000 Apr; 34 Suppl 2():S35-52. PubMed ID: 10915920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective.
    Diaz Brinton R; Chen S; Montoya M; Hsieh D; Minaya J; Kim J; Chu HP
    Neurobiol Aging; 2000; 21(3):475-96. PubMed ID: 10858597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An estrogen replacement therapy containing nine synthetic plant-based conjugated estrogens promotes neuronal survival.
    Zhao L; Chen S; Brinton RD
    Exp Biol Med (Maywood); 2003 Jul; 228(7):823-35. PubMed ID: 12876302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease.
    O'Neill K; Chen S; Diaz Brinton R
    Exp Neurol; 2004 Aug; 188(2):268-78. PubMed ID: 15246826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease.
    O'Neill K; Chen S; Brinton RD
    Exp Neurol; 2004 Jan; 185(1):63-80. PubMed ID: 14697319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons.
    Zhao L; Chen Q; Diaz Brinton R
    Exp Biol Med (Maywood); 2002 Jul; 227(7):509-19. PubMed ID: 12094016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials.
    Shimbo D; Wang L; Lamonte MJ; Allison M; Wellenius GA; Bavry AA; Martin LW; Aragaki A; Newman JD; Swica Y; Rossouw JE; Manson JE; Wassertheil-Smoller S
    J Hypertens; 2014 Oct; 32(10):2071-81; discussion 2081. PubMed ID: 24991872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models.
    Sohrabji F
    Ann N Y Acad Sci; 2005 Jun; 1052():75-90. PubMed ID: 16024752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway.
    Nilsen J; Chen S; Brinton RD
    Brain Res; 2002 Mar; 930(1-2):216-34. PubMed ID: 11879813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.
    Zhao L; O'Neill K; Brinton RD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1124-32. PubMed ID: 16951259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease.
    Simpkins JW; Green PS; Gridley KE; Singh M; de Fiebre NC; Rajakumar G
    Am J Med; 1997 Sep; 103(3A):19S-25S. PubMed ID: 9344403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can estrogen play a significant role in the prevention of Alzheimer's disease?
    Kesslak JP
    J Neural Transm Suppl; 2002; (62):227-39. PubMed ID: 12456066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons.
    Zhao L; Brinton RD
    Brain Res; 2007 Oct; 1172():48-59. PubMed ID: 17803971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hormone therapy, Premarin, impairs hippocampus-dependent spatial learning and memory and reduces activation of new granule neurons in response to memory in female rats.
    Barha CK; Galea LA
    Neurobiol Aging; 2013 Mar; 34(3):986-1004. PubMed ID: 22938820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?
    Brinton RD
    CNS Drugs; 2004; 18(7):405-22. PubMed ID: 15139797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health.
    Brinton RD
    Int J Fertil Womens Med; 1999; 44(4):174-85. PubMed ID: 10499738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equilin, a principal component of the estrogen replacement therapy premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism.
    Brinton RD; Proffitt P; Tran J; Luu R
    Exp Neurol; 1997 Oct; 147(2):211-20. PubMed ID: 9344546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.